PapersFlow Research Brief
Gene expression and cancer classification
Research Guide
What is Gene expression and cancer classification?
Gene expression and cancer classification is the analysis of microarray and RNA-seq gene expression data using normalization, differential expression, feature selection, machine learning, and clustering to classify cancer types and subtypes.
The field encompasses 384,825 papers on processing gene expression data from microarray experiments, including quality control and bioinformatics tools. Key methods involve real-time quantitative PCR with the 2−ΔΔCT method (Livak and Schmittgen, 2001) and differential expression analysis via edgeR (Robinson et al., 2009) and limma (Ritchie et al., 2015). Gene set enrichment analysis (GSEA) interprets genome-wide profiles (Subramanian et al., 2005).
Topic Hierarchy
Research Sub-Topics
Microarray Normalization Methods
This sub-topic develops algorithms like quantile and loess normalization to correct for technical biases in microarray data. Researchers evaluate methods for batch effects and platform-specific artifacts in gene expression studies.
Differential Expression Analysis
This sub-topic advances statistical models such as limma and edgeR for identifying significantly changed genes across conditions. Researchers focus on multiple testing correction and applications to cancer subtypes.
Gene Set Enrichment Analysis
This sub-topic uses tools like GSEA to interpret coordinated changes in biological pathways rather than individual genes. Researchers apply it to pathway dysregulation in cancer progression and treatment response.
Feature Selection in Gene Expression
This sub-topic explores techniques like recursive feature elimination and LASSO for high-dimensional gene selection in classifiers. Researchers optimize for cancer prognosis and diagnostic model performance.
Clustering Methods for Gene Expression
This sub-topic develops hierarchical, k-means, and model-based clustering to uncover cancer subtypes from expression profiles. Researchers validate clusters biologically and assess stability in large cohorts.
Why It Matters
Gene expression profiling enables precise cancer classification, as in DecisionDx-Melanoma, which analyzes 31 genes to assess sentinel lymph node positivity risk in melanoma patients (Castle Biosciences news, 2025). MammaPrint evaluates 70 genes to determine recurrence risk in early-stage breast cancer, the only FDA-cleared test for this purpose (Agendia news, 2025). Recent machine learning on PANCAN RNA-seq data uses SVM, KNN, AdaBoost, and Random Forest to classify cancer types (Sultana Akter, 2025). Tools like GAIN-BRCA integrate multi-omics for TCGA breast cancer PAM50 subtyping, while TULIP classifies RNA-seq into 17 or 32 tumor types.
Reading Guide
Where to Start
"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method" by Livak and Schmittgen (2001) provides the foundational method for relative quantification, essential before advanced classification analyses.
Key Papers Explained
Livak and Schmittgen (2001) establish PCR quantification, extended by Pfaffl (2001) with a mathematical model for RT-PCR. Subramanian et al. (2005) add GSEA for profile interpretation, while Robinson et al. (2009) and Ritchie et al. (2015) provide edgeR and limma for differential expression powering classification pipelines. Yu et al. (2012) enable clusterProfiler for theme comparison in gene lists from these analyses.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent preprints apply machine learning to RNA-seq for cancer classification, including Sultana Akter's (2025) evaluation of eight classifiers on PANCAN data and ensemble models on GSE50161 for brain tumors. GAIN-BRCA and moBRCA-net integrate multi-omics for breast cancer subtyping on TCGA. AI methods like HE2RNA predict transcriptome from slides with 0.79–0.84 correlations.
Papers at a Glance
In the News
Castle Biosciences' DecisionDx-Melanoma Test Earns ...
DecisionDx-Melanoma evaluates the activity of 31 genes in primary cutaneous melanoma tumor tissue to deliver a personalized risk classification. This helps clinicians more accurately assess the lik...
Machine learning approach to identify significant genes ...
Glob Med Genet . 2025 Oct 10;12(4):100079. doi: 10.1016/j.gmg.2025.100079 # Machine learning approach to identify significant genes and classify cancer types from RNA-seq data Sultana Akter ...
AI-based methods for modelling whole-slide imaging data in cancer diagnosis and transcriptome profile prediction
HE2RNA, SEQUOIA, and tRNAsformer which have been shown to predict gene expression with strong correlation scores (0.79–0.84). In conclusion, we take a look at key remaining challenges, including bi...
Gene expression profiling and predictive modeling of ...
study demonstrates that IoT-enabled biosensors, integrated with AI-driven predictive models, can revolutionize cancer monitoring by enabling real-time, non-invasive detection of biomarkers. The CNN...
Agendia Named 2025 “Best Overall Genomics Company” ...
MammaPrint is a gene expression profiling test that analyzes 70 genes to reveal the metastatic potential of an early-stage tumor and determine its risk of recurrence. It’s the only FDA-cleared gene...
Code & Tools
- **GAIN-BRCA** leverages multi‑omics datasets to classify TCGA breast cancer subtypes based on PAM50. - Integrates gene expression, DNA methylatio...
moBRCA-net is an omics-level attention-based breast cancer subtype classification framework that uses multi-omics datasets. Dataset integration was...
omicsGAT is a graph attention network based framework for cancer subtype analysis. It performs the task of classification or clustering of patient/...
TULIP is a 1D convolutional neural network for classifying RNA-Seq data with 60K genes or 19K protein coding genes . TULIP can classify either list...
This project aims to classify different types of cancer based on gene expression profiles using various machine learning models, including Random F...
Recent Preprints
Machine learning approach to identify significant genes ...
alternatives. This study aimed to evaluate machine learning algorithms on RNA-seq gene expression data to identify statistically significant genes and classify cancer types. We retrieved the PANCAN...
Gene expression profiling and predictive modeling of ...
data with greater speed, accuracy, and consistency 20 . One of the most impactful applications of ML in oncology is gene expression-based cancer classification. Using large datasets of gene express...
Gene Expression Data-Based Interpretable Machine ...
Early detection, therapeutic stratification, and precision medicine all rely on the precise classification of brain cancer subtypes. To categorize brain tumor subtypes, we examine the application...
Classification of Cancer Types based on Gene Expression Data
A not-for-profit organization, IEEE is the world's largest technical professional organization dedicated to advancing technology for the benefit of humanity. © Copyright 2024 IEEE - All rights res...
Pioneering AI Solutions for Cancer Subtype Classification ...
•This research examines mechanical learning as well as deep neural network models towards cancer subtype categorization, including their techniques, strengths, and limitations in processing gene ex...
Latest Developments
Recent developments in gene expression and cancer classification research include the use of multimodal feature-optimized approaches for microarray gene expression analysis to improve cancer classification accuracy (published November 2025) (nature.com), the development of novel algorithms such as the Grouping Genetic Algorithm (GGA) for RNA-seq data-based cancer classification (October 2024) (sciencedirect.com), and the application of multi-omics and deep learning techniques, including integrating image processing with neural networks, to enhance gene selection and tumor subtype classification (November 2025) (nature.com) and (nature.com).
Sources
Frequently Asked Questions
What is the 2−ΔΔCT method for gene expression analysis?
The 2−ΔΔCT method, described by Livak and Schmittgen (2001), uses real-time quantitative PCR for relative quantification of gene expression. It calculates fold changes by normalizing target gene CT values to a reference gene and control sample. This approach has 175,772 citations for its accuracy in low-abundance transcript studies.
How does limma perform differential expression analysis?
limma (Ritchie et al., 2015) is an R/Bioconductor package for analyzing microarray and RNA-seq data with linear models and empirical Bayes moderation. It handles complex experimental designs for gene expression experiments. The package has 40,321 citations.
What is Gene Set Enrichment Analysis (GSEA)?
GSEA, introduced by Subramanian et al. (2005), interprets genome-wide expression profiles by testing predefined gene sets for enrichment. It identifies subtle changes undetectable by individual gene analysis. The method has 54,051 citations.
What role does edgeR play in digital gene expression?
edgeR (Robinson et al., 2009) is a Bioconductor package for differential expression in digital gene expression data like RNA-seq. It models count data with negative binomial distribution. It has 42,343 citations.
How is machine learning applied to cancer classification from gene expression?
Machine learning classifiers like Random Forest, SVM, and CNN analyze RNA-seq data for cancer type classification, as in the PANCAN dataset evaluation (Sultana Akter, 2025). Ensemble models such as XGBoost classify brain tumor subtypes from GSE50161 data. Tools like TULIP use 1D CNN on 60K genes for 17-32 tumor types.
Open Research Questions
- ? How can multi-omics integration via graph attention networks improve accuracy in breast cancer subtyping beyond gene expression alone?
- ? What biological validation is needed for AI-predicted gene expression from whole-slide images, given correlation scores of 0.79–0.84?
- ? Which feature selection methods best balance statistical significance and interpretability in high-dimensional RNA-seq cancer classification?
- ? How do real-time IoT biosensors with CNN models enhance non-invasive cancer biomarker detection from gene expression?
- ? What limits deep neural networks in processing gene expression for rare cancer subtype classification?
Recent Trends
Papers grew to 384,825 works, with preprints shifting to machine learning on RNA-seq, evaluating SVM, Random Forest, XGBoost on PANCAN and GSE50161 datasets (Sultana Akter, 2025).
Commercial tests like DecisionDx-Melanoma (31 genes) and MammaPrint (70 genes) advance clinical use (2025 news).
Multi-omics tools GAIN-BRCA and TULIP classify subtypes and tumor types from integrated data.
Research Gene expression and cancer classification with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Gene expression and cancer classification with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers